Royal Bank Of Canada Pfizer Inc Put Options Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $1.97 Million - $2.26 Million	-76,100 Reduced 55.91%	60,000 $1.67 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $977,262 - $1.27 Million	37,400 Added 37.89%	136,100 $3.92 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $802,250 - $937,750	25,000 Added 33.92%	98,700 $3.27 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $2.66 Million - $3.08 Million	73,700 New	73,700 $2.7 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $9.31 Million - $11 Million	-200,000 Reduced 24.1%	630,000 $33 Million

Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $11.2 Million - $13.9 Million	245,000 Added 41.88%	830,000 $43 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $21.3 Million - $31.5 Million	515,000 Added 735.71%	585,000 $34.5 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $2.51 Million - $2.85 Million	70,000 New	70,000 $2.74 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.